Bactericidal/Permeability-Increasing Protein Preserves Leukocyte Functions After Major Liver Resection

Abstract

ObjectiveTo analyze postoperative leukocyte functions in patients undergoing hemihepatectomy, and to assess the effect of treatment with the endotoxin-neutralizing agent bactericidal/permeability-increasing protein (rBPI 21 ). Summary Background DataExtensive liver resection is associated with a high incidence of infectious complications. Because elimination of pathogenic microorganisms occurs mainly by leukocytes, this increased rate of infections is most likely due to an impaired function of these cells. Endotoxin, translocated from the gut into the systemic circulation as a result of increased gut permeability and reduced hepatic clearance function after major liver resection, may play an important role in the impairment of posthepatectomy leukocyte function. MethodsTo investigate whether hemihepatectomy results in impaired leukocyte functions and to determine the role of endotoxin in this process, leukocyte oxidative burst and leukocyte antigen expression were studied in three groups of patients: patients undergoing a hemihepatectomy and receiving rBPI 21 treatment, patients undergoing hemihepatectomy and receiving placebo, and as an extra control group patients undergoing other major abdominal surgeries.Blood samples were collected before surgery, 2 hours after surgery, and at days 1, 2, 5, and 7. Phorbol myristate acetate-stimulated oxidative burst was measured using dihydrorhodamine, and leukocyte surface expression of the antigens CD11b, CD16, and CD14 was investigated by indirect immunofluorescence. Both oxidative burst and membrane surface expression were quantified by flow cytometry. An indication of the antiendotoxin effect of rBPI 21 treatment was provided by assessment of plasma lipopolysaccharide binding protein (LBP) levels by enzyme-linked immunosorbent assay. ResultsThe oxidative burst in the hemihepatectomized patients receiving placebo and the controls increased 2 hours after surgery, whereas it decreased in the rBPI 21 -treated patients, resulting in significant differences between the groups. On day 1, neutrophil CD11b expression and monocyte CD14 expression in the rBPI 21 -treated patients and controls were significantly lower than in the placebo group. At 2 hours, CD16 expression in the placebo-treated patients was significantly higher than in the rBPI 21 -treated patients and controls. On day 5 and day 7, plasma LBP levels were significantly higher in the placebo-treated patients compared with the rBPI 21 -treated patients. ConclusionsThe results of this study show that patients undergoing major liver resection have an increased activation of leukocytes compared with those undergoing other major abdominal surgery. This enhanced activation may contribute to the increased risk of infection in these patients. Administration of the endotoxin-neutralizing agent rBPI 21 to hemihepatectomy patients was shown to reduce plasma LBP levels, to preserve leukocyte functions partially, and to reduce leukocyte activation to the level of other, nonhepatic abdominal surgery.Despite major advances in surg...

Increased bactericidal/permeability increasing protein in patients with cirrhosis

“…Yet it might be argued that the presence of elevated levels of LBP remains an indirect clue as to the role of endotoxin, as some other factors might stimulate LBP induction. However, this approach is also supported by the work of other authors (21–23) who have used LBP as a suitable indicator of endotoxaemia in different settings.…”

Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration

“…The mechanisms that initiate these responses are not known, but it has been suggested that the decreased ability of the resected liver to clear endotoxins released by the gut results in Kupffer cell activation (43). This activation in response to decreased innate immunity function parallels the activation of FXR by increased bile acid flux.…”

Effects of major liver resection, with or without recombinant bactericidal/permeability‐increasing protein (rBPI21), on the angiogenic profile of patients with metastatic colorectal carcinoma

“…Recombinant BPI (rBPI 21 ) is a 21-kDa amino-terminal protein derived from the 55-kDa human BPI 55 . RBPI 21 has the same bactericidal properties as the endogenous BPI [25,26]. The main object of this study was to determine the effects of liver surgery on the angiogenic profile in the circulation.…”